Bipartisan Lawmakers Are Fighting HHS’ 340B Rebate Push
A bipartisan group of six senators introduced a bill to reform the 340B drug program, locking in hospitals' use of contract pharmacies and adding new transparency and compliance rules. The legislation would also kill HHS' contested rebate pilot within a year and replace it with a national data clearinghouse to catch duplicate discounts.
Recovery for Replimune: Accelerated Approval for Cancer Drug Twice Spurned by FDA
Replimune went from an FDA rejection to a resubmission, a positive advisory committee vote, and finally an accelerated regulatory approval for advanced melanoma — all in less than four months. The FDA nod for Replimune’s oncolytic viral therapy, Tudriqev, positions it as a more convenient alternative to an Iovance Biotherapeutics cell therapy that had been the only treatment in this setting.
Democratic Senators Urge Withdrawal of Interim Final Rule on Medicaid Work Requirements
Democratic senators are urging CMS to withdraw its Medicaid work requirements rule, arguing it will create administrative burdens and cause eligible beneficiaries to lose coverage.
The Missing Piece of Preventive Dental Care Lies in the Bite
Historically, prevention has focused on protecting teeth from decay and gum disease. However, long-term oral health is also shaped by how the teeth, muscles, and jaw function together over time.
Healthcare Workplace Violence Prevention Needs Better Visibility Into Risk Signals
Gaps in prevention are not frequently due to a complete lack of information, but instead the fact that organizations don't have a clear way to see how the pieces fit together until after an incident has occurred.